DUBLIN, Ohio — Cardinal Health started putting its CareFusion spinoff cash to work, announcing it purchased $1.1 billion in debt for $1.2 billion.
Cardinal received $1.4 billion in proceeds from the spinoff, which became official last month. Repurchasing the debt was expected; Cardinal said it would use the money to reduce long-term debt.
It was a bit of an up-and-down week for Cardinal. Its stock dipped after a Deutsche Bank analyst downgraded the stock from a “buy” to a “hold.” The analyst, Ross Muken, praised new CEO George Barrett’s changes at the company but said the impact of those changes are at least a year away. However, the stock started regaining lost ground on Friday.
Survey on the Healthcare Financial Landscape Offers a Roadmap for Stakeholders
Zelis highlights how employers, payers, and consumers are integrating digital tools to manage healthcare costs.
Meanwhile, former CEO, R. Kerry Clark, is landing softly after his departure from Cardinal. Bausch & Lomb announced this week that Clark has joined its board of directors. The Associated Press reported this week that Clark in his final year at the company received more than $10 million in compensation — a 2 percent increase.
Related articles by Zemanta
- Cardinal Health puts its British Martindale business up for sale (medcitynews.com)
- Cardinal’s new anti-ivory tower CEO seeks big money from low margins (medcitynews.com)